Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A FIRST IN DISEASE PHASE 2A TRIAL OF GRANULOCYTE MONOCYTE COLONY STIMULATING FACTOR NEUTRALISATION FOR AXIAL SPONDYLOARTHRITIS (NAMASTE STUDY)

Conference paper

Al-Mossawi MH. et al, (2021), Clinical and experimental rheumatology, 39, 1161 - 1161

PROINFLAMMATORY OSTEOPONTIN AND CCL2 ARE SPONTANEOUSLY PRODUCED BY PSORIATIC ARTHRITIS SYNOVIAL MYELOID CELLS

Conference paper

Yager N. et al, (2021), Clinical and experimental rheumatology, 39, 1212 - 1212

GENETIC DETERMINANTS OF TRANSCRIPTIONAL VARIATION IN PRIMARY HUMAN MONOCYTES ACROSS MULTIPLE CONTEXTS

Conference paper

Nassiri I. et al, (2019), European journal of human genetics, 27, 1713 - 1714

Identification of transcriptomic markers predictive of clonal response to checkpoint inhibitor treatment

Conference paper

Watson RA. et al, (2019), European journal of immunology, 49, 1744 - 1745

Precision medicine in psoriatic arthritis: how should we select targeted therapies?

Journal article

Al-Mossawi H. et al, (2019), The lancet rheumatology, 1, e66 - e73

HIGH-DIMENSIONAL MULTIPARAMETRIC CHARACTERIZATION OF THE REGULATORY T CELLS LANDSCAPE IN SPONDYLOARTHRITIS

Conference paper

Simone D. et al, (2019), Annals of the rheumatic diseases, 78, 863 - 863

HIGH DIMENSIONAL PROFILING OF REGULATORY T CELLS IN SPONDYLOARTHRITIS REVEALS CELLULAR HETEROGENEITY

Conference paper

Simone D. et al, (2019), Annals of the rheumatic diseases, 78, A44 - A45

Process measure of FAST tuberculosis infection control demonstrates delay in likely effective treatment.

Journal article

Le H. et al, (2019), Int j tuberc lung dis, 23, 140 - 146

IMMUNE EFFECTOR CELLS IN SpA: WHAT ARE THE PATHWAYS?

Conference paper

(2018), Clinical and experimental rheumatology

Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases.

Journal article

Hammitzsch A. et al, (2018), Sci rep, 8

Personalized medicine - a new reality in psoriatic arthritis?

Journal article

Al-Mossawi H. and Coates LC., (2018), Nat rev rheumatol, 14, 449 - 451

Progress in our understanding of the pathogenesis of ankylosing spondylitis.

Journal article

Simone D. et al, (2018), Rheumatology (oxford), 57, vi4 - vi9

GENOTYPIC EFFECTS OF ANKYLOSING SPONDYLITIS ASSOCIATED IL7R POLYMORPHISMS ARE MEDIATED THROUGH MONOCYTES IN INFLAMMATION

Conference paper

Al-Mossawi MH. et al, (2018), Annals of the rheumatic diseases, 77, 191 - 191

Load More